/Mckesson%20Corporation%20logo%20on%20phone-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. Valued at a market cap of $105.2 billion, the company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
MCK is expected to release its Q4 2026 earnings on Thursday, May 7, after the market closes. Ahead of the event, analysts expect the company’s EPS to be $11.56 on a diluted basis, up 14.2% from $10.12 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.